138 related articles for article (PubMed ID: 10187941)
21. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
22. Validation of the Composite Laryngeal Recurrence Staging System.
Lacy PD; Kennedy JT; Piccirillo JF
Cancer; 2004 Aug; 101(4):761-7. PubMed ID: 15305407
[TBL] [Abstract][Full Text] [Related]
23. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of different TNM-based stage groupings for oral squamous cell carcinoma.
Kreppel M; Drebber U; Rothamel D; Eich HT; Kübler A; Scheer M; Zöller JE
Head Neck; 2011 Oct; 33(10):1467-75. PubMed ID: 21928419
[TBL] [Abstract][Full Text] [Related]
25. [Impact of extracapsular lymph node spread in the ipsilateral neck on contralateral neck metastasis and prognosis of laryngeal cancer].
Liu B; Guan C; Ji WY; Pan ZM
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):871-5. PubMed ID: 17416015
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
27. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma.
Fumic-Dunkic L; Katic V; Janjanin S; Klapan I; Simuncic A; Vcev A
Am J Otolaryngol; 2003; 24(2):106-10. PubMed ID: 12649825
[TBL] [Abstract][Full Text] [Related]
29. TNM-based stage groupings in head and neck cancer: application in cancer of the hypopharynx.
Hall SF; Groome PA; Irish J; O'Sullivan B
Head Neck; 2009 Jan; 31(1):1-8. PubMed ID: 19031408
[TBL] [Abstract][Full Text] [Related]
30. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
31. [Correlation between expression of p53 and prognosis of laryngeal squamous carcinoma].
Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Zhang Q
Ai Zheng; 2003 Jan; 22(1):77-82. PubMed ID: 12561442
[TBL] [Abstract][Full Text] [Related]
32. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G
Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092
[TBL] [Abstract][Full Text] [Related]
34. [Second primary lung cancer in laryngeal cancer patients: report on 36 cases].
Gao Y; Wang L; Zhang D
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):341-3. PubMed ID: 11783123
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Adult Comorbidity Evaluation 27 and the Charlson Comorbidity indices in patients with laryngeal squamous cell carcinoma.
Nesic VS; Petrovic ZM; Sipetic SB; Jesic SD; Soldatovic IA; Kastratovic DA
J Laryngol Otol; 2012 May; 126(5):516-24. PubMed ID: 22449728
[TBL] [Abstract][Full Text] [Related]
36. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
[TBL] [Abstract][Full Text] [Related]
38. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
39. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic management of laryngeal cancer. Results of a study of 356 patients from the Cancer Registry of the Somme, France.
Ayache S; Peng J; Chatelain D; De La Roche Saint-Andre G; Mineur O; Raverdy N; Dubreuil A; Krzisch C; Strunski V
Acta Otolaryngol; 2005 Dec; 125(12):1323-6. PubMed ID: 16303682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
